Skip to content

Covidien > USSC > Tyco > FDA approval for laparoscopic kit > Single Incision Laparoscopic Surgery SILS Procedure Kit > Natural Orifice Transluminal Endoscopic Surgery NOTES > NOSCAR Natural Orifice Surgery Consortium for Assessment and Research > SILS for general surgery > Urologic gynecologic and bariatric surgery application > Peritoneal access > Suturing > Anastomotic devices > Single skin incision in patient’s umbilicus

tyco.jpgDoes the SILS kit enable incision-less surgery that will improve patient outcomes? Is the SILS NOTES product development an initiative that was launched in 2007 in response to the 2007 business results? Will the new products have an impact on the reported 2007 net loss of $342 million on sales of $10.2 billion?

IIP >read on here > http://www.ad-hoc-news.de…

…Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that its Surgical Devices business unit has received FDA 510(k) clearance to market the Covidien SILS’ Procedure Kit, indicated for Single-Incision Laparoscopic Surgery and other advanced laparoscopic procedures.

The devices in the kit can be used by surgeons to conveniently perform laparoscopic procedures through a single skin incision located within the patient’s umbilicus, or belly button. The kit features several advanced articulating instruments and access ports, which enable improved access to the surgical site and maneuverability for tissue dissection and retraction.

The Covidien SILS’ Procedure Kit is scheduled for commercialization in the summer of 2008, and customized kit solutions are also forthcoming to enable SILS’ procedures for general surgery, urologic, gynecologic and bariatric surgery applications…

Covidien is actively working with surgeons around the world to develop even less invasive approaches for surgery, including Natural Orifice Transluminal Endoscopic Surgery (NOTES) performed through the body’s natural orifices. In 2007, the Company established the Covidien NOTES Research Fund in conjunction with NOSCARTM (Natural Orifice Surgery Consortium for Assessment and Research) to support clinical research in key technological areas of this new form of surgery, including peritoneal access, suturing and anastomotic devices…

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies…